LAUREN GREEN: Open Payments
NPI 1063075976 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,700 in 202 payments from 22 companies in 2025. Trend: 2023 $3,957 · 2024 $4,698 · 2025 $4,700
Food & beverage: $4,700
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $951 |
| Ardelyx, Inc. | 24 | $599 |
| Janssen Biotech, Inc. | 15 | $471 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $329 |
| Lilly USA, LLC | 9 | $278 |
| Madrigal Pharmaceuticals | 12 | $267 |
| QOL Medical, LLC | 11 | $255 |
| GENZYME CORPORATION | 9 | $203 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $183 |
| Ipsen Biopharmaceuticals, Inc | 7 | $163 |
Products named: TREMFYA, IBSRELA, RINVOQ, DUPIXENT, CREON, REZDIFFRA, Sucraid, ENTYVIO.
Industry payments across AL — which companies pay providers there.
